*  Vical's Phase 1/2 Trial Data Presented at ASM 2016 Shows Bivalent...
... placebo-controlled Phase 1/2 clinical trial of its therapeutic genital herpes vaccine in symptomatic herpes simplex virus type ... The slides presented by Mammen P. "Anza" Mammen, Jr., M.D., Vical's Vice President, Clinical Vaccines, will be accessible on ...
  http://tramatob.blogspot.com/2016/06/vicals-phase-12-trial-data-presented-at.html
*  Herpes Vaccine Update: An Interview With Penn's Dr. Harvey Friedman | American Council on Science and Health
HF: The primary animal models of herpes simplex virus (HSV) infection, mice, and guinea pigs, are a useful guide as to what to ... live attenuated vaccines?. HF: Live attenuated vaccines contain many more proteins than subunit vaccines, so they are perhaps ... of herpes simplex. Our goal is to attain what we call "sterilizing immunity," which means that the vaccine would prevent ... trivalent sub-unit herpes vaccine, given the recent disappointment of Genocea's GEN-003 vaccine candidate (1). ...
  https://www.acsh.org/news/2017/10/11/herpes-vaccine-update-interview-penns-dr-harvey-friedman-11940
*  Discuss: Is there a vaccine for herpes simplex virus infection? | Naked Science Forum
In this episode of the eLife podcast we hear about herpes, breweries, model organisms, social interactions in rats and ... Discuss: Is there a vaccine for herpes simplex virus infection? « on: 17/04/2015 12:01:28 » ... Discuss: Is there a vaccine for herpes simplex virus infection? *0 Replies ... In this episode of the eLife podcast we hear about herpes, breweries, model organisms, social interactions in rats and ...
  https://www.thenakedscientists.com/forum/index.php?topic=57043
*  WO2005028496A3 - Vaccine for treatment and prevention of herpes simplex virus infection - Google Patents
... comprising complexes of antigenic peptides and adjuvants that can activate an immune response against herpes viruses. The ... The present invention relates to methods and compositions for the prevention and treatment of herpes virus infections. The ... Recombinant herpes simplex gB-gD vaccine US5171568A (en) 1984-04-06. 1992-12-15. Chiron Corporation. Recombinant herpes simplex ... WO2005028496A3 - Vaccine for treatment and prevention of herpes simplex virus infection - Google Patents. Vaccine for treatment ...
  https://patents.google.com/patent/WO2005028496A3/en
*  A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a ...
A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a " ... A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a " ... A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a " ... New concepts in herpes simplex virus vaccine development: notes from the battlefield. Expert Rev Vaccines. 2009; 8: 1023-1035. ...
  https://iovs.arvojournals.org/article.aspx?articleid=2343104
*  Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human...
... were effective inhibitors of herpes simplex virus type 1 (HSV-1) entry (H. Bultmann and C. R. Brandt, J. Biol. Chem. 277:36018- ... The TAT-C peptide acted extracellularly, immediately blocked entry of adsorbed virus, prevented VP16 translocation to the ... of the human immunodeficiency virus tat protein (GRKKRRQRRR) ... of prophylactic and therapeutic herpes simplex virus vaccines. ... Inhibition of Herpes Simplex Virus Type 1 Infection by Cationic-Peptides. *Radeekorn Akkarawongsa, Terra B. Potocky, Emily P. ...
  https://www.semanticscholar.org/paper/Addition-of-a-C-terminal-cysteine-improves-the-of-a-Bultmann-Teuton/6ab39f39bf261330c29a411176b33411730f5914
*  Patent US20040095756 - LED flashlight with die-struck panel - Google Patents
Herpes simplex virus VP16 vaccines. US5730013 *. 2 Apr 1997. 24 Mar 1998. Huang; Wen-Sheng. Key structure with illumination ...
  http://www.google.ca/patents/US20040095756
*  Herpes simplex virus diagnostics - Chiron Corporation
Novel methods and immunodiagnostic test kits for diagnosing herpes simplex virus (HSV) infection are disclosed. The methods and ... A set of 738 randomly chosen serum samples, obtained as screening samples from individuals volunteering for HSV vaccine studies ... These infections are caused by two viruses, herpes simplex virus type 1 ("HSV-1") and herpes simplex virus type 2 ("HSV-2"). ... HERPES SIMPLEX VIRUS TYPE 2-GLYCOPROTEIN G PROTEINS AND POLYPEPTIDES. WO1992002251A1. 1992-02-20. HERPES SIMPLEX VIRUS VP16 ...
  http://www.freepatentsonline.com/5965354.html
*  Immunology
Live attenuated vaccines for herpes simplex virus. Subunit and viral-vectored vaccines for West Nile Virus, Bovine Coronavirus ... Specific research programs include: vaccine design for Brucella Abortus, West Nile Virus, Dengue Virus, Herpes viruses and ... Anti-viral immunity to human respiratory viruses focusing on the cellular and molecular mechanisms that regulate viral ... analysis of the innate and adaptive immune response to respiratory syncytial virus and human metapneumovirus infections, as ...
  http://lsu.edu/vetmed/pbs/research/immunology/
*  Citing LSHTM publications - The Lens - Free & Open Patent and Scholarly Search
Herpes Simplex Virus Combined Subunit Vaccines And Methods Of Use Thereof * Published: Jul 17, 2008 ... Preventing Infection By A Measles Or Respiratory Syncytial Virus * Published: Jul 17, 2008 ...
  https://www.lens.org/lens/collection/22851
*  Immunology and Infectious Disease | Medical School - University of Minnesota
He focuses on the study of CMV (Cytomegalovirus) vaccines, immunopathogenesis, and placental infection.Currently, Schleiss' lab ... Schacker was awarded with the Best Doctors in America award.Developing vaccines for infectious diseasesMark Schleiss, MD, ... Immune deficiencies in childrenEpidemiology and transmission of viral infections including herpes virusesImmune suppression ... Prospects and perspectives for development of a vaccine against herpes simplex virus infections. Expert Review of Vaccines 13( ...
  https://www.med.umn.edu/research/research-strengths-expertise/immunology-and-infectious-disease
*  herpes
After many setbacks, cross-presentation provides new hope for a Herpes Simplex Virus 1 vaccine. April 27, 2012. David Esteban 4 ... Herpes simplex virus type 1 (HSV-1) is making news due to a paper by Jing et al identifying two promising new candidate ... CD8cross-presentaitotnepitopeherpesHSV. Environmental virology, Guest Blogger Herpes-Family Viruses are Associated with ... Rejected titles included: Catching herpes from coral sex, Viruses and corals: friends or anemonies?, and Virus in the O.K. ...
  http://pages.vassar.edu/viva/?tag=herpes
*  Immunology
After many setbacks, cross-presentation provides new hope for a Herpes Simplex Virus 1 vaccine. April 27, 2012. David Esteban 4 ... Herpes simplex virus type 1 (HSV-1) is making news due to a paper by Jing et al identifying two promising new candidate ... As of yet a vaccine remains elusive. One reason why it is so difficult to create a vaccine is because HIV is highly mutable and ... The antibody apparently latches onto the virus's V3 loop and prevents the virus from invading cells. This does not mean that ...
  http://pages.vassar.edu/viva/?cat=887
*  Vaccines
After many setbacks, cross-presentation provides new hope for a Herpes Simplex Virus 1 vaccine. April 27, 2012. David Esteban 4 ... CD8cross-presentaitotnepitopeherpesHSV. Epidemics, Vaccines Does the Flu Vaccine Work?. September 28, 2011. David Esteban 10 ... Herpes simplex virus type 1 (HSV-1) is making news due to a paper by Jing et al identifying two promising new candidate ... antibodyHIVvaccine. Immunology, Molecular Virology, Vaccines Can miRNAs help further attenuate influenza A vaccines?. April 6, ...
  http://pages.vassar.edu/viva/?cat=931
*  HPV, HSV | Dermatology Times
Key developments in battling sexually transmitted viruses include a new version of the HPV vaccine that protects against nine ... Meanwhile, development of therapeutic vaccines for the herpes simplex virus (HSV) continues. ... RELATED: Teens & the HPV vaccine. Like the quadrivalent HPV vaccine, the nine-valent vaccine requires intramuscular injections ... Unlike a live or killed vaccine, adds Dr. Tyring, the new vaccine contains purely recombinant glycoproteins. 'That means there ...
  http://dermatologytimes.modernmedicine.com/dermatology-times/news/hpv-hsv
*  JoVE | Peer Reviewed Scientific Video Journal - Methods and Protocols
There is an unmet medical need for a prophylactic vaccine against herpes simplex virus (HSV). DNA vaccines and cutaneous ... Peripheral blood CD4 T-cell and plasmacytoid dendritic cell (pDC) reactivity to herpes simplex virus 2 and pDC number do not ... Leukocytes participate in the immune control of herpes simplex virus (HSV). Data from HIV coinfections, germ line mutations, ... DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge. ...
  https://www.jove.com/visualize?author=Angela+Shaulov+Kask
*  JCI - Volume 122, Issue 2
Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. ... Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. ... Herpes simplex virus type 1 (HSV-1) not only causes painful recurrent oral-labial infections, it can also cause permanent brain ... There is currently no HSV-1 vaccine. An effective vaccine must stimulate coordinated T cell responses, but the large size of ...
  https://jci.org/122/2
*  Orange County Medical Association > News > OCMA Blog |...
... innovative immunological studies on developing the first effective vaccine against herpes simplex virus; laser imaging of ...
  http://www.ocma.org/news/ocma-blog.aspx?BlogPage=21
*  Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection - Full Text View - ClinicalTrials...
Genital Herpes Herpes Simplex Virus Herpes Simplex Virus Vaccines HSV Vaccines Herpesvirus Vaccines Biological: HSV529 Phase 1 ... Herpes Simplex. Herpes Genitalis. Herpesviridae Infections. DNA Virus Infections. Virus Diseases. Skin Diseases, Viral. Skin ... Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1- ... Prior vaccination against herpes simplex virus.. *Known allergy or intolerance to vaccine components [e.g., potassium glutamate ...
  https://clinicaltrials.gov/ct2/show/NCT01915212?term=hsv529&rank=1
*  Patents filed at Oct 10 2017 | MetAP-2 inhibitor polymersomes for therapeutic administration | Patents.com
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response. Herpes Simplex Virus-2 ... EV71 virus-like particles and preparation method and application thereof. The present invention provides EV71 virus-like ... Highly effective vaccines and immunogenic compositions against HSV-2, which can be used... ... Compositions and methods for the treatment or prevention of human immunodeficiency virus infection. Disclosed are yeast-based ...
  http://patents.com/isd-20171010-p111.html
*  Peptides as Immunogens | SpringerLink
Immune Response to Synthetic Herpes Simplex Virus Peptides:The Feasibility of a Synthetic Vaccine ... The Value of Synthetic Peptides as Vaccines for Eliciting T-Cell Immunity ...
  https://link.springer.com/book/10.1007/978-3-642-71440-5
*  Tony Minson - Wikipedia
Herpes simplex type 2 (accessed 10 January 2013) Whitley, R. J.; Roizman, B. (2002). "Herpes simplex viruses: Is a vaccine ... "Recent progress in herpes simplex virus immunobiology and vaccine research". Clinical Microbiology Reviews. 16 (1): 96-113. doi ... including herpes simplex virus (HSV) and human cytomegalovirus. These large and complex enveloped DNA viruses commonly infect ... virus; similarly disabled viruses are also termed "single-cycle" viruses. Their work with DISC HSV-2 led to a series of vaccine ...
  https://en.wikipedia.org/wiki/Tony_Minson
*  KR100417593B1 - Dried blood factor composition containing trehalose - Google Patents
Vaccine for treatment and prevention of herpes simplex virus infection JP5037331B2 (en) * 2004-03-19. 2012-09-26. バクスター・インター ... Vaccines for the prevention and treatment of cancer Family Cites Families (21). * Cited by examiner, † Cited by third party. ... Protective agent in process for performing dry heat virus inactivation on high-purity prothrombin complex concentrate products ... so that essentially free of contaminating proteins is caused by a virus purification. 이 문제점을 해결하기 위한 재조합형 (recombinant) 인체 혈청 ...
  https://patents.google.com/patent/KR100417593B1/en
*  Recent Articles | Cloning, Genetics & Genomics And Disease/Medicine | The Scientist Magazine®| Page 70
A vaccine candidate against herpes simplex virus type 2 provides complete protection against infection in mice, with no ... A novel Ebola vaccine being tested in China is safe and provokes a notable immune response in people, according to a Phase 1 ...
  https://www.the-scientist.com/?articles.list/tagNo/435,9,6/tags/cloning,genetics--amp--genomics,disease-medicine/pageNo/70/
*  Herpes Simplex Virus Keratitis: A Treatment Guideline - 2014 - American Academy of Ophthalmology
HSV VACCINES. There are no FDA approved vaccines for the prevention of herpes simplex infection or recurrence. There have been ... Herpes simplex virus keratitis, includes entities with the following ICD-9 and ICD-10 classifications:. *Herpes simplex with ... Herpes simplex virus is typically spread by direct contact, most often from virus shed into saliva or genital secretions. ... There are promising data on the efficacy of a herpes simplex vaccine in the prevention of genital herpes. A randomized double- ...
  https://www.aao.org/clinical-statement/herpes-simplex-virus-keratitis-treatment-guideline